Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 4
1989 1
1990 1
1991 2
1992 2
1996 3
1997 4
1998 3
1999 1
2000 1
2001 2
2002 1
2003 4
2005 2
2006 3
2009 4
2010 1
2011 1
2012 1
2013 2
2014 4
2015 1
2016 1
2017 3
2018 2
2020 2
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Vaccine allergy: evidence to consider for COVID-19 vaccines.
Nilsson L, Csuth Á, Storsaeter J, Garvey LH, Jenmalm MC. Nilsson L, et al. Among authors: storsaeter j. Curr Opin Allergy Clin Immunol. 2021 Aug 1;21(4):401-409. doi: 10.1097/ACI.0000000000000762. Curr Opin Allergy Clin Immunol. 2021. PMID: 34091550 Free PMC article. Review.
Vaccination and allergy: EAACI position paper, practical aspects.
Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC, Gomes E, Jenmalm MC, Lau S, Netterlid E, Schwarze J, Sheikh A, Storsaeter J, Skevaki C, Terreehorst I, Zanoni G. Nilsson L, et al. Among authors: storsaeter j. Pediatr Allergy Immunol. 2017 Nov;28(7):628-640. doi: 10.1111/pai.12762. Epub 2017 Oct 10. Pediatr Allergy Immunol. 2017. PMID: 28779496 Free article. Review.
Cost-effectiveness of pneumococcal vaccination for elderly in Sweden.
Wolff E, Storsaeter J, Örtqvist Å, Naucler P, Larsson S, Lepp T, Roth A. Wolff E, et al. Among authors: storsaeter j. Vaccine. 2020 Jul 6;38(32):4988-4995. doi: 10.1016/j.vaccine.2020.05.072. Epub 2020 Jun 11. Vaccine. 2020. PMID: 32536548 Free article.
Waning infant pertussis during COVID-19 pandemic.
Falkenstein-Hagander K, Appelqvist E, Cavefors AF, Källberg H, Nilsson LJ, Silfverdal SA, Storsaeter J, Aronsson B. Falkenstein-Hagander K, et al. Among authors: storsaeter j. Arch Dis Child. 2022 Mar;107(3):e19. doi: 10.1136/archdischild-2021-323055. Epub 2021 Dec 2. Arch Dis Child. 2022. PMID: 34857511
How to make sense of pertussis immunogenicity data.
Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J. Olin P, et al. Among authors: storsaeter j. Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S288-91. doi: 10.1086/322564. Clin Infect Dis. 2001. PMID: 11709761 Review.
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team. Jahnmatz M, et al. Among authors: storsaeter j. Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17. Lancet Infect Dis. 2020. PMID: 32687804 Clinical Trial.
59 results